Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
about
Revisiting Crohn's disease as a primary immunodeficiency of macrophagesIdentification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's diseaseAn investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians.Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.Evidence of expression variation and allelic imbalance in Crohn's disease susceptibility genes NOD2 and ATG16L1 in human dendritic cellsInduction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileumA case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology.Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.Nucleotide oligomerization domain 2 polymorphisms in patients with intestinal failure.NOD1 and NOD2: signaling, host defense, and inflammatory disease.Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation.Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation.Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.Cutting edge: Crohn's disease-associated Nod2 mutation limits production of proinflammatory cytokines to protect the host from Enterococcus faecalis-induced lethalitySize does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity.Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn diseaseNOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease.NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African AmericansThe association between environmental exposures during childhood and the subsequent development of Crohn's disease: A score analysis approach.New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations.The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell wallsApical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene.Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's diseasePhenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.Role of Nod2 in the development of Crohn's disease.The immunopathogenesis of Crohn's disease: a three-stage model.Molecular epidemiology of nontuberculous mycobacteria.Genome-wide association studies and Crohn's disease.NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.Crohn's as an immune deficiency: from apparent paradox to evolving paradigm.Hydroxylases as therapeutic targets in inflammatory bowel disease.NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome.A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation.Understanding the regulation of pattern recognition receptors in inflammatory diseases - a 'Nod' in the right direction.Cross-tolerization between Nod1 and Nod2 signaling results in reduced refractoriness to bacterial infection in Nod2-deficient macrophages.Emerging drugs to treat Crohn's disease.
P2860
Q22242983-C7D6A6AB-60BF-4390-A7C8-EA0C17579929Q28080914-7E8597ED-D4CB-40ED-AEFA-0B72F19697F2Q31034250-85C45C28-2C50-4DD3-888A-1FBB02C67CD8Q33590163-F36BC07F-A8E9-4CD1-A885-CC6EDFC34C7EQ33760727-98EB703A-B22B-4E31-8001-5B3394D96709Q33815678-1DB2AE66-32BC-4041-8D24-E494E1FD6FAEQ33839876-0B75A1F0-09C6-4573-8C47-E0C0FDD7665BQ34056080-3C22C3CE-F354-4871-AFF5-CE3103AB40EFQ34093119-180C4885-04ED-465B-93A5-56556D47AEB6Q34195178-99000A86-E71C-47BD-8A29-8E3CB132F41CQ34258465-DD373B67-5FB5-4251-BFE5-4AA4A2D371A5Q34313205-A34B1B5B-1DBE-4F30-BF22-F52EBC14233EQ34745603-39949ABB-8AF8-4A38-83A8-2C4044063F59Q34944118-0EB7D4BA-4202-45ED-8F4E-6583B3DE2A59Q34973978-BB965B6B-7120-4373-88DC-02511B21F821Q35036733-C0E34C6B-8922-478C-BEA6-26A01A639D27Q35204635-487F1121-7FC2-40DF-ADF6-9854B7B29B95Q35376137-52F35632-8E42-4065-BEEC-F9CAB1BE6628Q35603251-035D0365-A164-4C13-BA5E-01A1001EB4F7Q35819548-D1962170-8D23-4B38-92F1-5CA4A29E41A6Q35919095-0E25FD43-AE21-4B19-AA24-E916D0C9BBE4Q36272975-C42AD688-61A9-4937-93B4-6FF86B1F6A55Q37038665-9E645491-DD27-4FCE-BCE9-883DEA224585Q37139051-A84D7D9C-3EF0-47A9-832D-7663DAA4FCE1Q37206258-90355879-C25F-4C34-87D2-0F017C1BD70FQ37261147-AB16FC1D-522A-4DC8-BD94-97C56D89F164Q37331540-56BBB2B7-7A1B-44B3-B4A7-615E4AB98B95Q37343481-77C470F4-930D-4431-894D-2B81B7D3423DQ37539114-EB3562AF-FFF5-4EFE-88E9-054B98673D2BQ37576645-09042866-46E3-4D75-9D94-87F63BFF3B56Q37613672-B6198F2C-2DF9-4B34-91C2-D59AD58A9919Q37857566-20F85948-7B25-461F-9EED-63298844C105Q38057238-B3EFA79C-8A62-421B-BC58-C3FC82A6B7FCQ38068957-AD76C071-92A2-41EA-99EB-35263A4CE738Q38082620-0F0AA088-2F98-4C87-80FE-C5F1AA8291BBQ38414222-88A0853B-5AEF-49E6-8FEA-DD6A22B0975DQ38855496-0D1FE172-235E-47AE-881B-AD09661CE8C7Q38972852-A96E1B7E-B440-41FB-BB05-5D000618FDE2Q39353816-DBE19A53-D613-4B93-A135-A619F493A0DEQ39881787-21DBDAAE-4475-40C4-B1B9-DC34632AB89E
P2860
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@ast
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@en
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@nl
type
label
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@ast
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@en
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@nl
prefLabel
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@ast
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@en
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@nl
P2093
P2860
P50
P1476
Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.
@en
P2093
Derek P Jewell
Elizabeth V Fowler
Huiying Yang
IBD International Genetics Consortium
Isabelle Zaccaria
Jack Satsangi
Juleen Cavanaugh
Maarit Lappalainen
Mark S Silverberg
P2860
P304
P356
10.1111/J.1572-0241.2007.01149.X
P407
P577
2007-02-23T00:00:00Z